Goldline Pharmaceutical Ltd Quarterly Result

Goldline Pharmaceutical Ltd Quarterly Result

Image

Goldline Pharmaceutical Ltd

NSE: GLPL

Net Profit - Last Quarter

₹ 1.89 Cr.

Last updated on: Jul 29, 2026

Goldline Pharmaceutical Ltd Quarterly Results Key Highlights

  • The revenue of Goldline Pharmaceutical Ltd for the Mar '26 is ₹ 9.79 crore as compare to the Dec '25 revenue of ₹ 7.52 crore.
  • This represent the growth of 30.19% The ebitda of Goldline Pharmaceutical Ltd for the Mar '26 is ₹ 2.78 crore as compare to the Dec '25 ebitda of ₹ 1.52 crore.
  • This represent the growth of 82.89% The net profit of Goldline Pharmaceutical Ltd for the Mar '26 is ₹ 1.89 crore as compare to the Dec '25 net profit of ₹ 0.87 crore.
  • This represent the growth of 117.24%.

Goldline Pharmaceutical Ltd Quarterly Results Analysis

Market Price of Goldline Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Goldline Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Jul 202637.66
27 Jul 202638.37
24 Jul 202638.13
22 Jul 202639.99
21 Jul 202641
20 Jul 202640.09
17 Jul 202640.49
16 Jul 202639.05
15 Jul 202639.02
14 Jul 202638.84

Historical Revenue of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Historical EBITDA of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Historical Net Profit of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Goldline Pharmaceutical Ltd News Hub

BSE SME Goldline Pharmaceutical delivers a dose of listing gains

The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc

Read more

19 May 26

Goldline Pharmaceutical to discuss results

Goldline Pharmaceutical will hold a meeting of the Board of Directors of the Company on 9 June 2026.

Read more

03 Jun 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Goldline Pharmaceutical Ltd

  • Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
  • Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
  • September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
  • Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
  • The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.

FAQs for Quarterly Results of Goldline Pharmaceutical Ltd

What key financial metrics are included in Goldline Pharmaceutical Ltd's quarterly results?

Key financial metrics in Goldline Pharmaceutical Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Goldline Pharmaceutical Ltd announce its quarterly results?

Goldline Pharmaceutical Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Goldline Pharmaceutical Ltd's quarterly performance impact its stock price?

Goldline Pharmaceutical Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Goldline Pharmaceutical Ltd's quarterly results on dividends?

The impact of Goldline Pharmaceutical Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Goldline Pharmaceutical Ltd's quarterly results?

Yes, Goldline Pharmaceutical Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions